Salud financiera de hoja de balance de Chi Sheng Pharma & Biotech
Salud financiera controles de criterios 5/6
Chi Sheng Pharma & Biotech has a total shareholder equity of NT$1.2B and total debt of NT$100.0M, which brings its debt-to-equity ratio to 8.3%. Its total assets and total liabilities are NT$1.8B and NT$582.7M respectively. Chi Sheng Pharma & Biotech's EBIT is NT$54.8M making its interest coverage ratio -3.5. It has cash and short-term investments of NT$440.6M.
Información clave
8.3%
Ratio deuda-patrimonio
NT$100.00m
Deuda
| Ratio de cobertura de intereses | -3.5x |
| Efectivo | NT$440.62m |
| Patrimonio | NT$1.21b |
| Total pasivo | NT$582.71m |
| Activos totales | NT$1.79b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Read This Before Buying Chi Sheng Pharma & Biotech Co., Ltd (GTSM:4111) For Its Dividend
Apr 06
A Look At The Fair Value Of Chi Sheng Pharma & Biotech Co., Ltd (GTSM:4111)
Mar 10Should Weakness in Chi Sheng Pharma & Biotech Co., Ltd's (GTSM:4111) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Feb 01
Here's What You Should Know About Chi Sheng Pharma & Biotech Co., Ltd's (GTSM:4111) 4.2% Dividend Yield
Jan 05Estimating The Fair Value Of Chi Sheng Pharma & Biotech Co., Ltd (GTSM:4111)
Dec 10Análisis de la situación financiera
Pasivos a corto plazo: 4111's short term assets (NT$816.1M) exceed its short term liabilities (NT$481.1M).
Pasivo a largo plazo: 4111's short term assets (NT$816.1M) exceed its long term liabilities (NT$101.6M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 4111 has more cash than its total debt.
Reducción de la deuda: 4111's debt to equity ratio has increased from 0% to 8.3% over the past 5 years.
Cobertura de la deuda: 4111's debt is well covered by operating cash flow (131.8%).
Cobertura de intereses: 4111 earns more interest than it pays, so coverage of interest payments is not a concern.